Device Listing Versus Trader Listing: Getting the Application Order Right

1. Key takeaways

Listing under the Medical Device Administrative Control System (MDACS) falls into two broad families: device listing and trader listing. The applicant for a device listing must be the local manufacturer, or a Local Responsible Person (LRP) appointed by the manufacturer. Trader listing covers 4 categories of entity: the LRP, the local manufacturer, the importer and the distributor. LRP listing is a hard prerequisite for device listing, and the direct consequence of getting the order wrong is that the application is returned at the acceptance stage, wasting the 12-week review window that had been reserved for it.

• Device listing is product-centred, while trader listing is entity-centred, and the two are applied for by different parties in different sequences.
• The LRP is both an applicant category in its own right and the route by which an overseas manufacturer reaches device listing.
• A single company may need more than one trader listing where it performs more than one function in the supply chain.
• Entity eligibility depends on Hong Kong, China incorporation or a business registration, and a valid business registration certificate is a common formal requirement.
• The revision of 1 September 2026 aligned the additional condition clauses across the importer, local manufacturer and distributor guidances.

2. Legal basis

The applicant eligibility rules sit in the overview published by the Medical Device Division (MDD), while the detail for each trader category sits in a separate guidance and in the code of practice for the Local Responsible Person. The table below records the instruments and provisions used in this article.

The structure of these instruments shows how MDACS divides responsibility. Product obligations are attached to the device listing, and entity obligations are attached to the trader listing that corresponds to the function performed. Because the device listing application is submitted by a party whose own standing depends on a trader listing, the sequence in which the applications are made is itself a compliance question rather than an administrative convenience.

3. Expert insights

First, the four trader listing categories are triggered by different activities. Importer listing corresponds to the step of bringing a device into Hong Kong, China; distributor listing corresponds to distributing a device within Hong Kong, China; local manufacturer listing corresponds to manufacturing in Hong Kong, China; and LRP listing corresponds to assuming local responsibility on behalf of an overseas manufacturer. A single company may need two or more trader listings at the same time, for example where it both imports and distributes, and each listing is assessed against its own guidance rather than being folded into a single application.

Second, entity eligibility is tied to business registration. An LRP must be a legal person incorporated in Hong Kong, China, or a natural person or legal person holding a business registration in Hong Kong, China. The common requirements for trader listing include holding a valid business registration certificate. Business registration status is the most frequent formal defect in this family of applications, and it is also the easiest to check before any drafting begins, which makes it a sensible first item on any project plan.

Third, the revision of 1 September 2026 unified the additional condition mechanism. Clause 7.5 of GN-07, clause 5.7 of GN-08 and clause 4.9 of GN-09 each contain an additional condition clause corresponding to clause 5.10 of GN-01. Four guidances were revised together, which indicates that MDD is managing conditional approvals of all listing types on a common footing. For applicants this means that a condition attached to an approval should be read in the same way regardless of which listing it sits on, and that the compliance response should be designed consistently across the group.

Fourth, local manufacturer listing carries a site inspection clause. Clause 4.10 of GN-08 requires the applicant to cooperate with an MDD site inspection during the application or after approval, including providing records and written procedures and allowing inspection of the business premises and the related storage or transport facilities. The obligation has to be allowed for in scheduling, because records that exist only in a regional system, or premises that are shared with a third party, take time to prepare for inspection.

4. Practical recommendations

• Fix the sequence. LRP listing first, then importer or distributor listing where needed, then device listing, then the expedited approval eligibility assessment.
• Check entity eligibility first. Confirm the Hong Kong, China incorporation status and the validity of the business registration certificate, and identify a local entity able to take the LRP role as early as possible.
• Avoid duplicate applications. Where a group entity already holds a trader listing of a given type, assess whether it can be used rather than filing a parallel application that adds management cost without adding coverage.
• Reserve time for inspection preparation. Before applying for local manufacturer listing, organise records, written procedures and storage and transport arrangements so that a site inspection does not become the critical path.

5. Verification checklist

• □ The company role in the supply chain has been confirmed (manufacturer, importer, distributor or LRP)
• □ LRP entity eligibility and business registration certificate have been verified
• □ The dependency order between the trader listings has been scheduled
• □ Site inspection preparation for local manufacturer listing is complete
• □ Additional conditions in each listing approval letter have been reviewed
• □ Expiry dates of all listing certificates are recorded in a single register

Regulatory information verified to 29 October 2026. The legislation, guidance and effective dates described in this article are limited to what the official sources listed under Legal basis had published on that date; where an official document has since been updated, the most recent published version prevails.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for Hong Kong, China. Our team manages MDACS listing applications across all risk classes, prepares reference-approval dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com